Literature DB >> 31019265

iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function.

Peiyan Ni1,2,3, Haneul Noh1,2, Gun-Hoo Park1, Zhicheng Shao2, Youxin Guan1, James M Park1, Sophy Yu1, Joy S Park1, Joseph T Coyle2, Daniel R Weinberger4, Richard E Straub4, Bruce M Cohen2, Donna L McPhie2, Changhong Yin5, Weihua Huang5, Hae-Young Kim6, Sangmi Chung7,8.   

Abstract

Schizophrenia (SCZ) is a neurodevelopmental disorder. Thus, studying pathogenetic mechanisms underlying SCZ requires studying the development of brain cells. Cortical interneurons (cINs) are consistently observed to be abnormal in SCZ postmortem brains. These abnormalities may explain altered gamma oscillation and cognitive function in patients with SCZ. Of note, currently used antipsychotic drugs ameliorate psychosis, but they are not very effective in reversing cognitive deficits. Characterizing mechanisms of SCZ pathogenesis, especially related to cognitive deficits, may lead to improved treatments. We generated homogeneous populations of developing cINs from 15 healthy control (HC) iPSC lines and 15 SCZ iPSC lines. SCZ cINs, but not SCZ glutamatergic neurons, show dysregulated Oxidative Phosphorylation (OxPhos) related gene expression, accompanied by compromised mitochondrial function. The OxPhos deficit in cINs could be reversed by Alpha Lipoic Acid/Acetyl-L-Carnitine (ALA/ALC) but not by other chemicals previously identified as increasing mitochondrial function. The restoration of mitochondrial function by ALA/ALC was accompanied by a reversal of arborization deficits in SCZ cINs. OxPhos abnormality, even in the absence of any circuit environment with other neuronal subtypes, appears to be an intrinsic deficit in SCZ cINs.

Entities:  

Year:  2019        PMID: 31019265      PMCID: PMC6813882          DOI: 10.1038/s41380-019-0423-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  99 in total

1.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

Review 2.  Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; Raymond Y Cho; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-03-17       Impact factor: 13.382

Review 3.  Postmortem human brain genomics in neuropsychiatric disorders--how far can we go?

Authors:  Andrew E Jaffe
Journal:  Curr Opin Neurobiol       Date:  2015-12-10       Impact factor: 6.627

Review 4.  Neurodevelopmental model of schizophrenia: update 2012.

Authors:  J L Rapoport; J N Giedd; N Gogtay
Journal:  Mol Psychiatry       Date:  2012-04-10       Impact factor: 15.992

Review 5.  Brain imaging in schizophrenia.

Authors:  K J Kotrla; D R Weinberger
Journal:  Annu Rev Med       Date:  1995       Impact factor: 13.739

6.  In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy.

Authors:  Fei Du; Alissa J Cooper; Thida Thida; Selma Sehovic; Scott E Lukas; Bruce M Cohen; Xiaoliang Zhang; Dost Ongür
Journal:  JAMA Psychiatry       Date:  2014-01       Impact factor: 21.596

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register.

Authors:  Rikke Hilker; Dorte Helenius; Birgitte Fagerlund; Axel Skytthe; Kaare Christensen; Thomas M Werge; Merete Nordentoft; Birte Glenthøj
Journal:  Biol Psychiatry       Date:  2017-09-01       Impact factor: 13.382

9.  Postmortem studies in schizophrenia.

Authors:  P J Harrison
Journal:  Dialogues Clin Neurosci       Date:  2000-12       Impact factor: 5.986

10.  Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative?

Authors:  Nicholas A Matigian; Richard D McCurdy; François Féron; Christopher Perry; Heather Smith; Cheryl Filippich; Duncan McLean; John McGrath; Alan Mackay-Sim; Bryan Mowry; Nicholas K Hayward
Journal:  PLoS One       Date:  2008-06-11       Impact factor: 3.240

View more
  17 in total

1.  CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.

Authors:  Valeria Kizner; Maximilian Naujock; Sandra Fischer; Stefan Jäger; Selina Reich; Ines Schlotthauer; Kai Zuckschwerdt; Tobias Geiger; Tobias Hildebrandt; Nathan Lawless; Thomas Macartney; Cornelia Dorner-Ciossek; Frank Gillardon
Journal:  Mol Neurobiol       Date:  2019-08-11       Impact factor: 5.590

Review 2.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

Review 3.  Epitranscriptomic dynamics in brain development and disease.

Authors:  Andrew M Shafik; Emily G Allen; Peng Jin
Journal:  Mol Psychiatry       Date:  2022-04-26       Impact factor: 15.992

4.  Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex.

Authors:  Kazuya Toriumi; Stefano Berto; Shin Koike; Noriyoshi Usui; Takashi Dan; Kazuhiro Suzuki; Mitsuhiro Miyashita; Yasue Horiuchi; Akane Yoshikawa; Mai Asakura; Kenichiro Nagahama; Hsiao-Chun Lin; Yuki Sugaya; Takaki Watanabe; Masanobu Kano; Yuki Ogasawara; Toshio Miyata; Masanari Itokawa; Genevieve Konopka; Makoto Arai
Journal:  Redox Biol       Date:  2021-06-24       Impact factor: 11.799

Review 5.  Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia.

Authors:  Peter James Michael Deans; Kristen J Brennand
Journal:  Curr Opin Neurobiol       Date:  2021-05-16       Impact factor: 7.070

Review 6.  Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.

Authors:  Michel Cuenod; Pascal Steullet; Jan-Harry Cabungcal; Daniella Dwir; Ines Khadimallah; Paul Klauser; Philippe Conus; Kim Q Do
Journal:  Mol Psychiatry       Date:  2021-11-10       Impact factor: 13.437

7.  Ketogenic Therapy in Serious Mental Illness: Emerging Evidence.

Authors:  Zoltán Sarnyai; Christopher M Palmer
Journal:  Int J Neuropsychopharmacol       Date:  2020-07-29       Impact factor: 5.176

8.  A proof of concept 'phase zero' study of neurodevelopment using brain organoid models with Vis/near-infrared spectroscopy and electrophysiology.

Authors:  Anirban Dutta; Sneha Sudhakar Karanth; Mahasweta Bhattacharya; Michal Liput; Justyna Augustyniak; Mancheung Cheung; Ewa K Stachowiak; Michal K Stachowiak
Journal:  Sci Rep       Date:  2020-12-02       Impact factor: 4.379

9.  Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia.

Authors:  Jianping Li; Sean K Ryan; Erik Deboer; Kieona Cook; Shane Fitzgerald; Herbert M Lachman; Douglas C Wallace; Ethan M Goldberg; Stewart A Anderson
Journal:  Transl Psychiatry       Date:  2019-11-18       Impact factor: 6.222

10.  Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis.

Authors:  Edward J Goetzl; Vinod H Srihari; Sinan Guloksuz; Maria Ferrara; Cenk Tek; George R Heninger
Journal:  Transl Psychiatry       Date:  2020-10-26       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.